Fideicomiso Irrevocable No. F/1523

BMV:FIBRAHD 15 Stock Report

Market Cap: Mex$1.1b

Fideicomiso Irrevocable No. F/1523 Balance Sheet Health

Financial Health criteria checks 1/6

Fideicomiso Irrevocable No. F/1523 has a total shareholder equity of MX$4.0B and total debt of MX$3.0B, which brings its debt-to-equity ratio to 73.9%. Its total assets and total liabilities are MX$7.2B and MX$3.2B respectively. Fideicomiso Irrevocable No. F/1523's EBIT is MX$372.5M making its interest coverage ratio 1.6. It has cash and short-term investments of MX$478.2M.

Key information

73.9%

Debt to equity ratio

Mex$2.96b

Debt

Interest coverage ratio1.6x
CashMex$478.24m
EquityMex$4.00b
Total liabilitiesMex$3.23b
Total assetsMex$7.23b

Recent financial health updates

No updates

Recent updates

What Type Of Returns Would Fideicomiso Irrevocable No. F/1523's(BMV:FIBRAHD15) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Mar 16
What Type Of Returns Would Fideicomiso Irrevocable No. F/1523's(BMV:FIBRAHD15) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Fideicomiso Irrevocable No. F/1523 (BMV:FIBRAHD15) Has Returned Negative 17% To Its Shareholders In The Past Five Years

Dec 01
Fideicomiso Irrevocable No. F/1523 (BMV:FIBRAHD15) Has Returned Negative 17% To Its Shareholders In The Past Five Years

Financial Position Analysis

Short Term Liabilities: FIBRAHD 15's short term assets (MX$1.0B) exceed its short term liabilities (MX$221.4M).

Long Term Liabilities: FIBRAHD 15's short term assets (MX$1.0B) do not cover its long term liabilities (MX$3.0B).


Debt to Equity History and Analysis

Debt Level: FIBRAHD 15's net debt to equity ratio (62%) is considered high.

Reducing Debt: FIBRAHD 15's debt to equity ratio has increased from 51.2% to 73.9% over the past 5 years.

Debt Coverage: FIBRAHD 15's debt is not well covered by operating cash flow (0.4%).

Interest Coverage: FIBRAHD 15's interest payments on its debt are not well covered by EBIT (1.6x coverage).


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/29 06:22
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Fideicomiso Irrevocable No. F/1523 is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sofía RoblesIntercam Casa de Bolsa S.A. de C.V.